BioSpace News Archive

Forbion Builds On Previous Success with 5th Life Sciences Fund Worth $545 Million

Investors in the fund include a variety of existing and new limited partners, both groups made up of specialized institutional and corporate investors.

December 8, 2020
·
3 min read
·
Mark Terry
Policy

Report: Trump Admin Turned Down Chance for More Pfizer COVID-19 Vaccines, Scrambles to Secure Now

President Trump has repeatedly assured U.S. citizens his administration would secure enough COVID-19 vaccine doses to protect the nation. However, a new report shows his government failed to act in securing additional doses of Pfizer and BioNTech’s vaccine this summer.

December 8, 2020
·
4 min read
·
Alex Keown
Biotech Beach

Biopharma Money on the Move: December 2 - 8

December is bringing frost in the North and plenty of cold, hard cash for these life sciences companies.

December 8, 2020
·
6 min read
·
Kate Goodwin
Drug Development

Biotechs Developing Innovative Ways to Activate the Immune System Against COVID-19

BioSpace spoke with a few companies that have some ingenious ideas at different stages of preclinical and clinical development.

December 8, 2020
·
7 min read
·
Heather McKenzie
Bioniz’s 3-Pronged Anti-Cytokine Therapy Halts Rare Cancer Proliferation and Inflammation

Data from a Phase I/II clinical trial was presented Saturday during the 62nd ASH Annual Meeting and Exposition (ASH).

December 8, 2020
·
4 min read
·
Gail Dutton
Business

Putting a New Spin on RNA, Remix Launches with $81 Million

The funds will be used to support the development of the company’s REMaster technology platform. In addition, Remix will now be able to advance its pipeline of RNA processing targeted therapeutics as well.

December 8, 2020
·
3 min read
·
Krystle Vermes
Business

Startup Grabs $100 Million to Focus on China’s Untapped CNS Market

SciNeuro Pharmaceuticals, based in Shanghai, China, launched with a $100 million Series A financing.

December 8, 2020
·
2 min read
·
Mark Terry
Policy

Year-End Deadline Has Celgene CVR Investors Holding Their Breath for FDA Approval

Is there still hope for Celgene shareholders who hold the $9 per share Contingent Value Rights tickets despite the cold water that seemed to dash the chances of required goals necessary for those payoffs?

December 8, 2020
·
2 min read
·
Alex Keown
Policy

FDA Likely to Report Pfizer-BioNTech COVID-19 Vaccine is Safe and Effective, Push to EUA

The document prepared and released by FDA staff indicates scientists from the agency plan to tell the advisory committee on Thursday that the available clinical trial data are adequate to support its safe and effective use in public immunization programs.

December 8, 2020
·
2 min read
·
Brandon May
Business

Novotech Health Holdings Announces Appointment of Anand Tharmaratnam as Chairman

Novotech Health Holdings, the largest biotech specialist contract research organization in Asia, announced the appointment of Anand Tharmaratnam as Chairman of the Board commencing 1 April 2021.

December 8, 2020
·
3 min read